Paul Vezina to Dopamine Antagonists
This is a "connection" page, showing publications Paul Vezina has written about Dopamine Antagonists.
Connection Strength
0.351
-
Blockade of D-1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre- and postsynaptic indices of dopamine function in the nucleus accumbens. Synapse. 1994 Feb; 16(2):104-12.
Score: 0.113
-
Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res. 1989 Aug 28; 495(2):401-6.
Score: 0.083
-
Blockade of D2 dopamine receptors in the VTA induces a long-lasting enhancement of the locomotor activating effects of amphetamine. Behav Pharmacol. 2004 Sep; 15(5-6):387-95.
Score: 0.059
-
D1 dopamine receptor blockade prevents the facilitation of amphetamine self-administration induced by prior exposure to the drug. Psychopharmacology (Berl). 1998 Jul; 138(2):159-66.
Score: 0.038
-
Activation of metabotropic glutamate receptors in the rat nucleus accumbens increases locomotor activity in a dopamine-dependent manner. J Pharmacol Exp Ther. 1997 Nov; 283(2):962-8.
Score: 0.037
-
The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res. 1989 Oct 09; 499(1):108-20.
Score: 0.021